09 February 2020 : Animal Research
Basic Fibroblast Growth Factor (bFGF) Protects the Blood–Brain Barrier by Binding of FGFR1 and Activating the ERK Signaling Pathway After Intra-Abdominal Hypertension and Traumatic Brain Injury
Peng Chen12ABCE, Hao Tang1C, Qingtao Zhang2E, Lei Xu2C, Wei Zhou2F, Xi Hu2D, Yongbing Deng2DEG, Lianyang Zhang1AG*DOI: 10.12659/MSM.922009
Med Sci Monit 2020; 26:e922009
Abstract
BACKGROUND: Intra-abdominal hypertension (IAH) is associated with high morbidity and mortality. IAH leads to intra-abdominal tissue damage and causes dysfunction in distal organs such as the brain. The effect of a combined injury due to IAH and traumatic brain injury (TBI) on the integrity of the blood–brain barrier (BBB) has not been investigated.
MATERIAL AND METHODS: Intracranial pressure (ICP) monitoring, brain water content, EB permeability detection, immunofluorescence staining, real-time PCR, and Western blot analysis were used to examine the effects of IAH and TBI on the BBB in rats, and to characterize the protective effects of basic fibroblast growth factor (bFGF) on combined injury-induced BBB damage.
RESULTS: Combined injury from IAH and TBI to the BBB resulted in brain edema and increased intracranial pressure. The effects of bFGF on alleviating the rat BBB injuries were determined, indicating that bFGF regulated the expression levels of the tight junction (TJ), adhesion junction (AJ), matrix metalloproteinase (MMP), and IL-1β, as well as reduced BBB permeability, brain edema, and intracranial pressure. Moreover, the FGFR1 antagonist PD 173074 and the ERK antagonist PD 98059 decreased the protective effects of bFGF.
CONCLUSIONS: bFGF effectively protected the BBB from damage caused by combined injury from IAH and TBI, and binding of FGFR1 and activation of the ERK signaling pathway was involved in these effects.
Keywords: Blood-Brain Barrier, Brain Injuries, intra-abdominal hypertension, Receptor, Fibroblast Growth Factor, Type 1, Brain Edema, Brain Injuries, Traumatic, endothelial cells, Fibroblast Growth Factor 2, Intracranial Pressure, Matrix Metalloproteinases, Microvessels, Permeability, Phosphorylation, Protective Agents, Protein Binding, Tight Junction Proteins
Editorial
01 September 2024 : Editorial
Editorial: Reasons for Increasing Global Concerns for the Spread of MpoxDOI: 10.12659/MSM.946343
Med Sci Monit 2024; 30:e946343
In Press
Clinical Research
Comparison of Remimazolam and Dexmedetomidine for Sedation in Awake Endotracheal Intubation in Scoliosis Su...Med Sci Monit In Press; DOI: 10.12659/MSM.944632
Database Analysis
Knowledge, Awareness, and Use of Stainless-Steel Crowns Among Dental Professionals in Sana'a City, YemenMed Sci Monit In Press; DOI: 10.12659/MSM.945948
Clinical Research
Disability Assessment with WHODAS 2.0 of People with Fibromyalgia in Poland: A Cross Sectional-StudyMed Sci Monit In Press; DOI: 10.12659/MSM.945450
Clinical Research
Enhanced Differentiation of Amiodarone-Induced Thyrotoxicosis Types Using Semi-Quantitative 99mTc-MIBI Upta...Med Sci Monit In Press; DOI: 10.12659/MSM.945444
Most Viewed Current Articles
17 Jan 2024 : Review article 6,054,137
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research 1,840,956
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 693,106
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
07 Jan 2022 : Meta-Analysis 257,521
Efficacy and Safety of Light Therapy as a Home Treatment for Motor and Non-Motor Symptoms of Parkinson Dise...DOI :10.12659/MSM.935074
Med Sci Monit 2022; 28:e935074